Clinical Trial Update: Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea [Phase 2]

View source ↗

Summary

A randomized, open-label Phase 2 trial evaluated oral AZD0914 for gonorrhea; the study has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• AZD0914

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Gonorrhoea | Phase 2 | Status: COMPLETED | Results posted: 2017-02-08